BNTX:NASDAQ
BioNTech SE - ADR
US$88,08
arrow_downward
-1,69%(-1,51) 1D
US$88,75
arrow_upward
+0,76% (+0,67)bedtimeAfter hours
Closed: 5 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BNTX...
Open
US$89,51
High
US$89,95
Low
US$87,75
Mkt. cap
໒໒,໒໗ ຕື້
Avg. vol.
໘໙໖,໔໘ ພັນ
Volume
໘໓໗,໔໔ ພັນ
52-wk high
US$123,98
52-wk low
US$79,52
EPS
US$-5,89
Beta
໑,໓໐
Shares outstanding
໒໕໒,໘໘ ລ້ານ
No. of employees
໘ ພັນ
Open
US$89,51
High
US$89,95
Low
US$87,75
Mkt. cap
໒໒,໒໗ ຕື້
Avg. vol.
໘໙໖,໔໘ ພັນ
Volume
໘໓໗,໔໔ ພັນ
52-wk high
US$123,98
52-wk low
US$79,52
EPS
US$-5,89
Beta
໑,໓໐
Shares outstanding
໒໕໒,໘໘ ລ້ານ
No. of employees
໘ ພັນ
Analyst outlook
Analyst Ratings
Based on 18 analysts giving stock ratings to BNTX in the past 3 months
Strong Buy
Buy
15
Hold
3
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for BNTX in the last 3 months.
Highest
Current US$88,08
US$167,00 (+89,60%)
Average
US$131,39 (+49,17%)
Lowest
US$94,00 (+6,72%)
News stories
From sources across the web
AD HOC NEWS
·
19 ຊົ່ວໂມງກ່ອນ
BioNTech Stock Under Siege: Technical Breakdown, Reform Jitters, and a Pipeline That Can’t Catch a
Investing.com
·
19 ຊົ່ວໂມງກ່ອນ
Bernstein reiterates BioNTech stock rating on pumitamig risks
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
AI content may include mistakes. Learn more